| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |